Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters











Database
Language
Publication year range
1.
PLoS One ; 17(1): e0261893, 2022.
Article in English | MEDLINE | ID: mdl-35073323

ABSTRACT

Combating the spread of antimicrobial resistance (AMR) among bacteria requires a new class of antimicrobials, which desirably have a narrow spectrum because of their low propensity for the spread of AMR. Antimicrobial peptides (AMPs), which target the bacterial cell membrane, are promising seeds for novel antimicrobials because the cell membrane is essential for all cells. Previously, we reported the antimicrobial and haemolytic effects of a natural AMP, magainin 2 (Mag2), isolated from the skin of Xenopus laevis (the African clawed frog), four types of synthesised Mag2 derivatives, and three types of rationally designed AMPs on gram-positive and gram-negative bacteria. To identify novel antimicrobial seeds, we evaluated the effect of AMPs on Mycoplasma pneumoniae, which also exhibits AMR. We also evaluated the antimicrobial effects of an AMP, NK2A, which has been reported to have antimicrobial effects on Mycoplasma bovis, in addition to Mag2 and previously synthesised seven AMPs, on four strains of M. pneumoniae using colorimetric, biofilm, and killing assays. We found that three synthesised AMPs, namely 17base-Ac6c, 17base-Hybrid, and Block, had anti-M. pneumoniae (anti-Mp) effect at 8-30 µM, whereas others, including NK2A, did not have any such effect. For the further analysis, the membrane disruption activities of AMPs were measured by propidium iodide (PI) uptake assays, which suggested the direct interaction of AMPs to the cell membrane basically following the colorimetric, biofilm, and killing assay results. PI uptake assay, however, also showed the NK2A strong interaction to cell membrane, indicating unknown anti-Mp determinant factors related to the peptide sequences. Finally, we conclude that anti-Mp effect was not simply determined by the membrane disruption activities of AMPs, but also that the sequence of AMPs were important for killing of M. pneumoniae. These findings would be helpful for the development of AMPs for M. pneumoniae.


Subject(s)
Anti-Bacterial Agents , Biofilms/drug effects , Drug Design , Magainins , Mycoplasma pneumoniae/physiology , Xenopus Proteins , Animals , Anti-Bacterial Agents/chemical synthesis , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacology , Biofilms/growth & development , Magainins/chemical synthesis , Magainins/chemistry , Magainins/pharmacology , Mycoplasma bovis/physiology , Xenopus Proteins/chemical synthesis , Xenopus Proteins/chemistry , Xenopus Proteins/pharmacology , Xenopus laevis
2.
Methods Enzymol ; 618: 1-27, 2019.
Article in English | MEDLINE | ID: mdl-30850047

ABSTRACT

Posttranslational modifications of histone proteins regulate all biological processes requiring access to DNA. Monoubiquitination of histone H2B is a mark of actively transcribed genes in all eukaryotes that also plays a role in DNA replication and repair. Solution and structural studies of the mechanism by which histone ubiquitination modulates these processes depend on the ability to generate homogeneous preparations of nucleosomes containing ubiquitin conjugated to a specific lysine residue. We describe here methods for generating milligram quantities of histone H2B with ubiquitin (Ub) conjugated to Lys 120 via either a nonhydrolyzable, dichloroacetone linkage or a cleavable isopeptide bond. H2B-Ub with an isopeptide linkage is generated by a combination of intein-fusion protein derivatization and native chemical ligation, yielding a fully native ubiquitinated lysine that can be cleaved by Ub isopeptidases. We also describe how to reconstitute nucleosomes containing ubiquitinated H2B.


Subject(s)
Histones/chemical synthesis , Ubiquitin/chemical synthesis , Xenopus Proteins/chemical synthesis , Xenopus laevis , Animals , Histones/chemistry , Histones/genetics , Hydrolysis , Lysine/chemical synthesis , Lysine/chemistry , Lysine/genetics , Models, Molecular , Ubiquitin/chemistry , Ubiquitin/genetics , Ubiquitination , Xenopus Proteins/chemistry , Xenopus Proteins/genetics , Xenopus laevis/genetics
3.
Langmuir ; 34(37): 11147-11155, 2018 09 18.
Article in English | MEDLINE | ID: mdl-30122046

ABSTRACT

The synergistic effect of antimicrobial compounds is an important phenomenon that can increase the potency of treatment and might be useful against the formation of biofilms on surfaces. A strong inhibition of microbial viability on surfaces can potentially delay the development of biofilms on treated surfaces, thereby enhancing the performance of water-purification technologies and medical devices, for example, to prevent hospital-acquired infections. However, the synergistic effects of surface-immobilized antimicrobial peptides (AMPs) have not yet been reported. Here, we demonstrate the synergistic antimicrobial effects of the AMPs PGLa and magainin-2 on modified reverse-osmosis (RO) membranes. These AMPs are known to act synergistically in the free state, but their antimicrobial synergistic effects have not yet been reported in a surface-immobilized state. The AMPs were functionalized with alkyne linkers and covalently attached to RO membranes modified with azides, using a click chemistry reaction. The resulting RO membranes showed reduced contact angles, indicating increased wettability. X-ray photoelectron spectroscopy confirmed the presence of the two peptides on the membranes via changes in the amounts of carbon, oxygen, and sulfur, which led to an increased S/C ratio, probably because of the sulfur present in the methionine residue of the peptides. The synergistic activity was measured with the free peptides in solution and covalently bound on RO membrane surfaces by observing increased leakage of 5(6)-carboxyfluorescein from large unilamellar vesicles. The synergistic antimicrobial activity against Pseudomonas aeruginosa was observed using surface-activity assays, where the AMP-modified RO membranes showed an effective inhibition of P. aeruginosa biofilm growth, as compared with unmodified membranes. An enhanced activity of antimicrobials on surfaces might lead to potent antimicrobial surfaces, which could result in more fouling-resistant water-treatment membranes.


Subject(s)
Anti-Bacterial Agents/chemistry , Antimicrobial Cationic Peptides/chemistry , Biofouling/prevention & control , Magainins/chemistry , Xenopus Proteins/chemistry , Animals , Anti-Bacterial Agents/chemical synthesis , Biofilms/drug effects , Magainins/chemical synthesis , Membranes, Artificial , Pseudomonas aeruginosa/drug effects , Xenopus Proteins/chemical synthesis , Xenopus laevis
4.
J Am Chem Soc ; 135(42): 15738-15741, 2013 Oct 23.
Article in English | MEDLINE | ID: mdl-24102563

ABSTRACT

High-resolution structure elucidation has been challenging for the large group of host-defense peptides that form helices on or within membranes but do not manifest a strong folding propensity in aqueous solution. Here we report the crystal structure of an analogue of the widely studied host-defense peptide magainin 2. Magainin 2 (S8A, G13A, G18A) is a designed variant that displays enhanced antibacterial activity relative to the natural peptide. The crystal structure of magainin 2 (S8A, G13A, G18A), obtained for the racemic form, features a dimerization mode that has previously been proposed to play a role in the antibacterial activity of magainin 2 and related peptides.


Subject(s)
Anti-Bacterial Agents/pharmacology , Magainins/metabolism , Phenylalanine/chemistry , Xenopus Proteins/metabolism , Anti-Bacterial Agents/chemical synthesis , Anti-Bacterial Agents/chemistry , Bacillus subtilis/drug effects , Crystallography, X-Ray , Dimerization , Dose-Response Relationship, Drug , Enterococcus faecium/drug effects , Escherichia coli/drug effects , Magainins/chemical synthesis , Magainins/chemistry , Microbial Sensitivity Tests , Models, Molecular , Staphylococcus aureus/drug effects , Structure-Activity Relationship , Xenopus Proteins/chemical synthesis , Xenopus Proteins/chemistry
5.
Peptides ; 33(2): 197-205, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22289499

ABSTRACT

Antimicrobial peptides (AMPs) are a naturally occurring component of the innate immune response of many organisms and can have activity against both Gram-negative and Gram-positive bacterial species. In order to optimize and improve the direct antimicrobial effect of AMPs against a broad spectrum of bacterial species, novel synthetic hybrids were rationally designed from cecropin A, LL-37 and magainin II. AMPs were selected based on their α-helical secondary structure and fragments of these were analyzed and combined in silico to determine which hybrid peptides would form the best amphipathic cationic α-helices. Four hybrid peptides were synthesized (CaLL, CaMA, LLaMA and MALL) and evaluated for direct antimicrobial activity against a range of bacterial species (Bacillus anthracis, Burkholderia cepacia, Francisella tularensis LVS and Yersinia pseudotuberculosis) alongside the original 'parent' AMPs. The hybrid peptides showed greater antimicrobial effects than the parent AMPs (in one case a parent is completely ineffective while a hybrid based on it removes all traces of bacteria by 3h), although they also demonstrated higher hemolytic properties. Modifications were then carried out to the most toxic hybrid AMP (CaLL) to further improve the therapeutic index. Modifications made to the hybrid lowered hemolytic activity and also lowered antimicrobial activity by various degrees. Overall, this work highlights the potential for rational design and synthesis of improved AMPs that have the capability to be used therapeutically for treatment of bacterial infections.


Subject(s)
Anti-Bacterial Agents/pharmacology , Antimicrobial Cationic Peptides/pharmacology , Magainins/pharmacology , Recombinant Fusion Proteins/pharmacology , Xenopus Proteins/pharmacology , Amino Acid Sequence , Anti-Bacterial Agents/chemical synthesis , Anti-Bacterial Agents/chemistry , Antimicrobial Cationic Peptides/chemical synthesis , Antimicrobial Cationic Peptides/chemistry , Bacillus anthracis/drug effects , Burkholderia cepacia/drug effects , Erythrocytes/drug effects , Francisella tularensis/drug effects , Hemolysis/drug effects , Humans , Hydrophobic and Hydrophilic Interactions , Magainins/chemical synthesis , Magainins/chemistry , Microbial Sensitivity Tests , Models, Molecular , Molecular Sequence Data , Peptide Fragments , Protein Structure, Secondary , Recombinant Fusion Proteins/chemical synthesis , Recombinant Fusion Proteins/chemistry , Xenopus Proteins/chemical synthesis , Xenopus Proteins/chemistry , Yersinia pseudotuberculosis/drug effects , Cathelicidins
6.
J Phys Chem B ; 113(14): 4846-52, 2009 Apr 09.
Article in English | MEDLINE | ID: mdl-19267489

ABSTRACT

Antimicrobial peptide magainin 2 forms pores in lipid membranes to induce leakage of internal contents of cells, which is a main cause of its bactericidal activity. However, the conditions and the mechanism of its pore formation remain unclear. In this report, to reveal the effect of the surface charge density of membranes on magainin 2-induced pore formation, we investigated the interaction of magainin 2 with giant unilamellar vesicles (GUVs) composed of a mixture of electrically neutral dioleoylphosphatidylcholine (DOPC) and negatively charged dioleoylphosphatidylglycerol (DOPG) in various ratios, using the single GUV method. We found that magainin 2 induced pores in the membranes of all kinds of single GUVs. For GUVs with the same charge density, the rate of the pore formation increased with magainin 2 concentration. The magainin 2 concentrations in a buffer required to induce the same rate of the pore formation greatly increased with a decrease in the surface charge density; e.g., the magainin 2 concentrations required for the pore formation in 30% DOPG/70% DOPC-GUVs were 50 times higher than those in 60% DOPG/40% DOPC-GUVs. However, after we converted the magainin 2 concentration in the buffer into that in the membrane interface, Xbmag, we found that Xbmag mainly determines the rate of the pore formation in various GUVs. These data support our model of two-state transition from the binding state to the pore state of the GUV for magainin 2-induced pore formation.


Subject(s)
Antimicrobial Cationic Peptides/metabolism , Antimicrobial Cationic Peptides/pharmacology , Membrane Lipids/metabolism , Unilamellar Liposomes/metabolism , Xenopus Proteins/metabolism , Xenopus Proteins/pharmacology , Antimicrobial Cationic Peptides/chemical synthesis , Antimicrobial Cationic Peptides/chemistry , Binding Sites , Biological Transport, Active , Magainins , Membrane Lipids/chemistry , Models, Biological , Phosphatidylcholines/chemistry , Phosphatidylcholines/metabolism , Phosphatidylglycerols/chemistry , Phosphatidylglycerols/metabolism , Surface Properties , Time Factors , Unilamellar Liposomes/chemistry , Xenopus Proteins/chemical synthesis , Xenopus Proteins/chemistry
7.
J Pept Sci ; 10(5): 298-303, 2004 May.
Article in English | MEDLINE | ID: mdl-15160842

ABSTRACT

In order to elucidate the structure-antiviral activity relationship of cecropin A (1-8)-magainin 2 (1-12) (termed CA-MA) hybrid peptide, several analogues with amino acid substitutions were synthesized. In a previous study, it was shown that serine at position 16 in CA-MA hybrid peptide was very important for antimicrobial activity. Analogues were designed to increase the hydrophobic property by substituting a hydrophobic amino acid residue (S --> A, V, F or W, position 16) in the CA-MA hybrid peptide. In this study, the structure-antiviral activity relationships of CA-MA and its analogues were investigated. In particular, substitution of Ser with a hydrophobic amino acid, Val, Phe or Trp at position 16 caused a dramatic increase in the virus-cell fusion inhibitory activity. These results suggested that the hydrophobicity at position 16 in the hydrophobic region of CA-MA is important for potent antiviral activity.


Subject(s)
Anti-Infective Agents/pharmacology , Antimicrobial Cationic Peptides/pharmacology , HIV Envelope Protein gp120/metabolism , HIV Envelope Protein gp41/metabolism , HIV-1/metabolism , Recombinant Fusion Proteins/pharmacology , Structure-Activity Relationship , Xenopus Proteins/pharmacology , Animals , Anti-Infective Agents/chemical synthesis , Antimicrobial Cationic Peptides/chemical synthesis , CD4 Antigens/genetics , CD4 Antigens/metabolism , Chlorocebus aethiops , Giant Cells/drug effects , HIV Envelope Protein gp120/genetics , HIV Envelope Protein gp41/genetics , HIV-1/genetics , HeLa Cells , Humans , Magainins , Recombinant Fusion Proteins/chemical synthesis , Vaccinia virus/genetics , Vero Cells , Xenopus Proteins/chemical synthesis
SELECTION OF CITATIONS
SEARCH DETAIL